Paris Cedex 13

• CBD-SIB - Efficacy of cannabidiol in the management of Self-Injurious Behavior in children and adolescents with severe neurodevelopmental di … Pending
  2025-521161-27-00 4 Children and adolescents with severe neurodevelopmental disorders
• A Study to Determine if Nomlabofusp is Effective and Safe in Adults and Children with Friedreich’s Ataxia Pending
  2025-521628-31-00 5 Friedreich’s ataxia is the most common inherited ataxia in humans and
• Electrophysiological analysis of Gamma-Hydroxybutyrate-induced sleep in intensive care patients: A Pilot Double-Blind Randomized Controlled … Pending
  2025-521967-11-00 4 The study population includes adult ICU patients with a hospitalizatio
• ILHEP : Effect of perioperative Intravenous Lidocaine on postoperative opioid related-side effects after open HEPatectomy: a multicentre pro … Pending
  2025-522462-73-00 6 Postanesthetic complications in patients undergoing open hepatectomy
• Trial assessing treatment in patients with advanced Lung Cancer and Interstitial Lung Disease Pending
  2025-522790-10-00 4 Non Small Cell Lung Cancer
• Personnalized immunotherapy in patients with stage III non-small cell lung cancer Pending
  2025-522801-39-00 4 Stage III Non Small Cell Lung Cancer
• A pivotal clinical study to investigate the safety and efficacy of efimosfermin alfa injection in participants with biopsyconfirmed F2- or F … Pending
  2025-523675-39-00 5 Metabolic Dysfunction-Associated Steatohepatitis (MASH)
• Methylphenidate for Early Awakening in Coma (MEAWAKE) Pending
  2025-524937-19-00 4 Coma due to acute brain injury
• Multicentre study evaluating the efficacy of a 7-day course of doxycycline for the treatment of asymptomatic anal lymphogranuloma venereum S … Pending
  2025-524978-42-00 4 Asymptomatic anal LGV infection
• A Study of Treatments for the Prevention of Disease Progression in Individuals at Risk for or With Early Onset Alzheimer’s Disease Caused by … Recruiting
  2024-517187-36-01 10 2026-06-24 Dominantly Inherited Alzheimer’s Disease (DIAD)
• A trial to compare treatment with surlorian (ARM210, S48168) to placebo in effects on muscle strength and safety in adults with autosomal do … Recruiting
  2025-522343-18-00 4 2026-06-12 Autosomal Dominant RYR1-Related Myopathy
• A Study of Transition Regimens to KPL-387 Monotherapy in Participants with Well-Controlled Recurrent Pericarditis Recruiting
  2025-523234-66-00 4 2026-04-17 Well-Controlled Recurrent Pericarditis
• KHENERFIN Recruiting
  2025-522361-30-00 5 2026-03-17 Primary Mitochondrial Disease, Mitochondrial DNA 3243A>G variant and A
• A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy. Recruiting
  2025-522553-19-00 10 2026-02-25 Symptomatic genetic and familial dilated cardiomyopathy.
• A study comparing nadofaragene firadenovec with standard of care in adults with an increased risk that non-muscle invasive bladder cancer ma … Recruiting
  2024-512029-10-00 5 2025-12-05 Intermediate risk, non-muscle invasive bladder cancer
• A Phase III Randomised, Open Label Trial of an Intradermal or Subcutaneous booster dose of MVA-BN Vaccine to Investigate MPXV Immunogenicity … Recruiting
  2024-518007-22-00 5 2025-12-05 Prevention of monkeypox (mpox) infection
• Long-term safety and efficacy study of riliprubart in participants with CIDP Recruiting
  2024-517032-22-00 5 2025-06-10 Immune system diseases.
• Belimumab CTD-ILD - Long Term Extension/Follow up to pivotal studies BLISSc-ILD and BEconneCTD-ILD Recruiting
  2023-509370-39-00 5 2025-06-03 connective tissue diseases
• Dose dense re-challenge of high dose methotrexate (hd-mtx) with glucarpidase (cpg2) for relapsed primary cns lymphoma (pcnsl): A phase 1 tri … Recruiting
  2024-511900-17-00 3 2025-02-14 Oncology: RELAPSED PRIMARY CNS LYMPHOMA
• Concentration of ofatumumab in the breast milk of lactating women with relapsing forms of multiple sclerosis Recruiting
  2023-505283-11-00 6 2024-12-10 Relapsing forms of Multiple Sclerosis (RMS)
• Fecal transplantation to Eradicate Colonizing Emergent Superbugs Recruiting
  2024-516393-29-00 5 2024-12-03 Patients colonized with MDR-GNB
• Efficacy and Safety of a New Formulation of Oral Cladribine Compared with Placebo in Participants with Generalized Myasthenia Gravis (MyCla … Recruiting
  2023-507746-83-00 5 2024-11-27 Generalized Myasthenia Gravis
• Lessening Organ Dysfunction with VITamin C in septic ARDS Recruiting
  2024-516394-78-00 5 2024-11-05 Patient with sepsis complicated by ARDS
• A Phase 1b study to investigate safety and tolerability of ARGX-119 in adult participants with DOK7 Congenital Myasthenic Syndrome (CMS) Recruiting
  2023-509872-41-00 9 2024-09-24 congenital neuromuscular disorders

Showing 25–48 of 314 trials